Skip to main content

Controlling avian #influenza #spillover #events: a modelling study

Image
By G.M.

Abstract

Avian influenza is a highly contagious viral disease that affects both domestic and wild birds, with occasional spillover to mammals, including humans. As of June 2025, 117 H5N1 infections in humans have been reported worldwide since 2020. Given the ability of the virus to infect mammals, there is a growing concern about its potential for human-to-human transmission. Currently, contact tracing and self-isolation are used in the UK to manage contacts of confirmed human cases of avian influenza. In this study, we aimed to estimate potential outbreak sizes and evaluate the effectiveness of contact tracing and self-isolation in managing avian influenza spillover events. We used a novel dataset from the Avian Contact Study to analyse contact patterns within an agricultural population at high risk of avian influenza exposure through contact with birds. We modelled outbreak sizes using a stochastic branching process model with measured contact data. Most simulations resulted in small-scale outbreaks, ranging from 0 to 10 cases. When the basic reproduction number was 1.1, contact tracing and self-isolation reduced the average outbreak size from 41 cases (95% Confidence Interval (CI): 37-46 cases) to 7 cases (95% CI: 6-8 cases), preventing, on average, 8 out of every 10 infections. However, they became less effective in reducing the outbreak size when a higher proportion of cases were asymptomatic. Overall, our findings suggest that contact tracing and self-isolation can be effective at preventing zoonotic infections. Increasing awareness, encouraging self-isolation, and detecting asymptomatic cases through routine surveillance are important components of zoonotic infection containment strategies.


Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding for the Avian Contact Study was awarded by PolicyBristol from the Research England QR Policy Support Fund (QR PSF) 2022-24 for investigating Zoonotic spillover of avian influenza. AT is funded by the Wellcome Trust, Early Career Award [227041/Z/23/Z]. EBP and IA acknowledge support from the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation and Behavioural Science at the University of Bristol (NIHR207385).

Source: MedRxIV, https://www.medrxiv.org/content/10.1101/2025.07.22.25331905v1

____

Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »